Antibe Therapeutics

(ATBPF)

By |

Profile

Antibe Therapeutics Inc develops safer, non-addictive medicines for pain and inflammation. Its technology involves linking a hydrogen sulfide-releasing molecule to an existing drug to produce an improved and patented medicine. The company's drug, ATB-346, targets the global need for a safer, non-addictive drug for chronic pain and inflammation. ATB-352, the second drug in pipeline, targets the urgent global need for a non-addictive analgesic for treating severe acute pain, while ATB-340 is a GI-safe derivative of aspirin. Its operating segment includes Antibe and Citagenix. The company generates maximum revenue from Citagenix segment and geographically from Canada. Citagenix segment is a marketer and distributor of regenerative medicines serving the dental and orthopaedic market places.

Contact Information

Website: www.antibethera.com
Main Phone: +1 416 922-3460
Address: 15 Prince Arthur Avenue
State: ON
City / Town: Toronto
Country: CA
Postal Code: M5R 1B2

Issuer Information

Exchange: OTCQX
CEO: Daniel Legault
Employees: 44
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Antibe Therapeutics Inc develops safer, non-addictive medicines for pain and inflammation. Its technology involves linking a hydrogen sulfide-releasing molecule to an existing drug to produce an improved and patented medicine. The company's drug, ATB-346, targets the global need for a safer, non-addictive drug for chronic pain and inflammation. ATB-352, the second drug in pipeline, targets the urgent global need for a non-addictive analgesic for treating severe acute pain, while ATB-340 is a GI-safe derivative of aspirin. Its operating segment includes Antibe and Citagenix. The company generates maximum revenue from Citagenix segment and geographically from Canada. Citagenix segment is a marketer and distributor of regenerative medicines serving the dental and orthopaedic market places.

Contact Information

Website: www.antibethera.com
Main Phone: +1 416 922-3460
Address: 15 Prince Arthur Avenue
State: ON
City / Town: Toronto
Country: CA
Postal Code: M5R 1B2

Issuer Information

Exchange: OTCQX
CEO: Daniel Legault
Employees: 44
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 3.59 $ -0.09 (-2.45%)
Last Price 3.59 Change $ -0.09 Change % -2.45 Tick N/A
Bid 3.58 Bid Size 6,900.00 Ask 3.63 Ask Size 1,900.00
Open 3.05 High 3.80 Low 3.05 Prev Close 3.68
Last Trade Volume 773 52 Wk Hi 5.89 52 Wk Low 2.22
Market Cap 163.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 45,538,266.00 EPS (TTM) -0.03 PE Ratio -6.60 Exchange OTCQX